TrialInternational journal of clinical oncology2016

Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701).

Koki Nakanishi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.